HP and gastric cancer: There was a higher degree of HP IgG antibody positivity in gastric cancer patients than in the control group (77.4% vs. 70.6%), and HP‐infected individuals showed a 1.43‐fold (95% CI: 1.12–1.81) increase in the risk of gastric cancer when compared with HP‐negative individuals.